167 related articles for article (PubMed ID: 14675415)
1. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis.
King MJ; Smythe JS; Mushens R
Br J Haematol; 2004 Jan; 124(1):106-13. PubMed ID: 14675415
[TBL] [Abstract][Full Text] [Related]
2. Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins.
King MJ; Jepson MA; Guest A; Mushens R
Int J Lab Hematol; 2011 Apr; 33(2):205-11. PubMed ID: 21054813
[TBL] [Abstract][Full Text] [Related]
3. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
[TBL] [Abstract][Full Text] [Related]
4. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
[TBL] [Abstract][Full Text] [Related]
5. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia.
King MJ; Behrens J; Rogers C; Flynn C; Greenwood D; Chambers K
Br J Haematol; 2000 Dec; 111(3):924-33. PubMed ID: 11122157
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
[TBL] [Abstract][Full Text] [Related]
7. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis.
Ciepiela O; Kotuła I; Górska E; Stelmaszczyk-Emmel A; Popko K; Szmydki-Baran A; Adamowicz-Salach A; Demkow U
Clin Chem Lab Med; 2013 Apr; 51(4):817-23. PubMed ID: 23023797
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
Wang J; Zheng B; Zhao Y; Chen X; Liu Y; Bo L; Zheng Y; Zhang F; Ru K; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):598-601. PubMed ID: 26304086
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of band 3 protein of human erythrocytes.
Stoya G; Baumann E; Junker U; Hermann J; Linss W
Acta Histochem; 1997 Mar; 99(1):29-36. PubMed ID: 9150794
[TBL] [Abstract][Full Text] [Related]
10. Hereditary spherocytosis diagnosed with the eosin-5'-maleimide binding test.
Watanabe T; Ono H; Tajima I; Ishigaki H; Hakamata A; Shirai M; Endoh A; Hongo T
Pediatr Int; 2014 Jun; 56(3):427-9. PubMed ID: 24894931
[TBL] [Abstract][Full Text] [Related]
11. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
[TBL] [Abstract][Full Text] [Related]
12. Are the Reference Ranges and Cutoff Values of Eosin-5'-Maleimide (EMA) Binding Test for Hereditary Spherocytosis Specific for Each Age Group?
Falay M; Ulusan GE; Şenes M; Acar IO
Clin Lab; 2018 Jun; 64(6):1101-1103. PubMed ID: 29945336
[No Abstract] [Full Text] [Related]
13. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
[TBL] [Abstract][Full Text] [Related]
14. Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients.
D'Alcamo E; Agrigento V; Sclafani S; Vitrano A; Cuccia L; Maggio A; Perrotta S; Capra M; Rigano P
Acta Haematol; 2011; 125(3):136-40. PubMed ID: 21150181
[No Abstract] [Full Text] [Related]
15. Flow cytometry as a diagnostic tool for hereditary spherocytosis.
Stoya G; Gruhn B; Vogelsang H; Baumann E; Linss W
Acta Haematol; 2006; 116(3):186-91. PubMed ID: 17016037
[TBL] [Abstract][Full Text] [Related]
16. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.
Christensen RD; Agarwal AM; Nussenzveig RH; Heikal N; Liew MA; Yaish HM
J Perinatol; 2015 May; 35(5):357-61. PubMed ID: 25357094
[TBL] [Abstract][Full Text] [Related]
17. [Flowcytometric diagnostics of hereditary spherocytosis].
Riley CH; Nikolajsen K; Kjaersgaard E; Klausen TW; Mourits-Andersen T; Clausen N; Lausen B; Rosthøj S; Birgens H
Ugeskr Laeger; 2009 Nov; 171(49):3610-4. PubMed ID: 19954702
[TBL] [Abstract][Full Text] [Related]
18. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders.
Tachavanich K; Tanphaichitr VS; Utto W; Viprakasit V
Southeast Asian J Trop Med Public Health; 2009 May; 40(3):570-5. PubMed ID: 19842445
[TBL] [Abstract][Full Text] [Related]
19. Biochemical, Cellular, and Proteomic Characterization of Hereditary Spherocytosis Among Tunisians.
Trabelsi N; Bouguerra G; Haddad F; Ouederni M; Darragi I; Boudrigua I; Chaouachi D; Barmat M; Fouzai C; Bejaoui M; Menif S; Kraiem I; Abbes S
Cell Physiol Biochem; 2021 Mar; 55(1):117-129. PubMed ID: 33667330
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of the degree of band 3 protein absence on erythrocyte membrane by eosin-5'-maleimide binding test and clinical phenotype in hereditary spherocytosis].
Peng GX; Yang WR; Jing LP; Zhang L; Zhou K; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Wu ZJ; Yang Y; Xiong YZ; Wang HJ; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):537-541. PubMed ID: 28655100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
